1YR.F

Healthcare Diagnostics & Research

Immunovia AB (publ)

€0.00

-0.00 -46.15% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 12:08 PM ET	0.00

Key Stats

Market Cap

470,866.808

Avg Volume

EPS

-€0.01

52W High

€0.01

52W Low

€0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.03

Margins

Gross Margin 57.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

323.3%

Return on Equity

(427.0%)

Return on Assets

(124.9%)

Liquidity & Leverage

Current Ratio

1.57

Quick Ratio

1.55

Debt / Equity

0.14

About

Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.